Sort   by:  
 Page size 
UnknownCopper mediated amyloid-β binding to Transthyretin.
Not available
S-EPMC6137083 | biostudies-literature
UnknownMultiple sclerosis-disease modifying therapies affect humoral and T-cell response to mRNA COVID-19 vaccine.
Not available
S-EPMC9753571 | biostudies-literature
UnknownIxazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial.
Not available
S-EPMC8651653 | biostudies-literature
UnknownLenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi.
Not available
S-EPMC3815174 | biostudies-literature
UnknownEndocarditis and Hypertrophic Cardiomyopathy.
Not available
S-EPMC11911852 | biostudies-literature
UnknownS101: OMISSION OF RADIOTHERAPY IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA PATIENTS FOLLOWING COMPLETE METABOLIC RESPONSE TO STANDARD IMMUNOCHEMOTHERAPY: RESULTS OF THE IELSG37 RANDOMISED TRIAL (NCT01599559)
Not available
S-EPMC10428398 | biostudies-literature
UnknownRole of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: final results of FIL HD0801 trial.
Not available
S-EPMC8579271 | biostudies-literature
UnknownStereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysis.
Not available
S-EPMC8897730 | biostudies-literature
UnknownImpact of Pre-Treatment Comorbidity Burden on Survival in Patients Receiving Venetoclax Plus Hypomethylating Agents.
Not available
S-EPMC11886493 | biostudies-literature
UnknownP1680: HEALTH-RELATED QUALITY OF LIFE IN TRANSPLANT-INELIGIBLE REAL-LIFE MULTIPLE MYELOMA PATIENTS TREATED WITH FIXED-DURATION BORTEZOMIB-MELPHALAN-PREDNISONE VS. CONTINUOUS LENALIDOMIDE-DEXAMETHASONE
Not available
S-EPMC10430276 | biostudies-literature
Sort   by:  
 Page size